Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound decisions in

Using a genetics-informed, precision medicine approach, the company seeks to establish proof-of-concept early in drug development

Retension Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing RTN-001 as a therapy for patients with hypertension.

ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,

Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency

TK-90 has completed “proof of concept” in Phase 2a clinical studies demonstrating safety and efficacy in head and neck cancer patients...

The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms

Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...

The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue

This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...

The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system

BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.

the company offers an app and teletherapy services designed to provide accessible, inclusive, and comprehensive mental health support

R3 Vascular will use the proceeds to support the ELITE FDA IDE trial of its bioresorbable scaffold, MAGNITUDE, for below-the-knee pad

oloSeal™ has the potential to help over 100,000 patients annually who undergo colorectal surgeries

Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors.

With its autonomous blood draw technology Vitestro is transforming the blood draw industry globally.